Obermeyer Wood Investment Counsel Lllp Cut By $623,200 Its Metlife (MET) Holding; 5 Analysts Covering Dairy Crest Group plc (LON:DCG)

April 24, 2018 - By Richard Conner

MetLife, Inc. (NYSE:MET) Logo

Obermeyer Wood Investment Counsel Lllp decreased Metlife Inc (MET) stake by 2.95% reported in 2017Q4 SEC filing. Obermeyer Wood Investment Counsel Lllp sold 12,464 shares as Metlife Inc (MET)’s stock declined 10.38%. The Obermeyer Wood Investment Counsel Lllp holds 410,636 shares with $20.76M value, down from 423,100 last quarter. Metlife Inc now has $49.76B valuation. The stock increased 1.27% or $0.6 during the last trading session, reaching $48. About 2.05 million shares traded. MetLife, Inc. (NYSE:MET) has declined 1.24% since April 24, 2017 and is downtrending. It has underperformed by 12.79% the S&P500.

Among 14 analysts covering Dairy Crest Group (LON:DCG), 5 have Buy rating, 3 Sell and 6 Hold. Therefore 36% are positive. Dairy Crest Group had 99 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Dairy Crest Group plc (LON:DCG) earned “Neutral” rating by JP Morgan on Friday, February 12. Jefferies downgraded it to “Hold” rating and GBX 640 target in Tuesday, November 10 report. The rating was upgraded by Investec on Tuesday, July 18 to “Buy”. JP Morgan maintained Dairy Crest Group plc (LON:DCG) rating on Friday, May 20. JP Morgan has “Neutral” rating and GBX 600 target. The stock has “Neutral” rating by Credit Suisse on Thursday, February 9. The stock of Dairy Crest Group plc (LON:DCG) earned “Buy” rating by HSBC on Tuesday, October 20. Shore Capital maintained the stock with “House Stock” rating in Wednesday, December 21 report. The firm has “Buy” rating by Peel Hunt given on Friday, September 8. Numis Securities downgraded the stock to “Hold” rating in Monday, September 19 report. The firm earned “Buy” rating on Friday, February 5 by HSBC. See Dairy Crest Group plc (LON:DCG) latest ratings:

24/04/2018 Broker: Barclays Capital Rating: Equal Weight New Target: GBX 580.00 Initiates Starts
14/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 680.00 New Target: GBX 650.00 Maintain
01/02/2018 Broker: Kepler Cheuvreux Rating: Reduce Old Target: GBX 560.00 New Target: GBX 560.00 Maintain
31/01/2018 Broker: Numis Securities Rating: Add Old Target: GBX 655.00 New Target: GBX 655.00 Maintain
17/01/2018 Broker: Numis Securities Rating: Add Old Target: GBX 655.00 New Target: GBX 655.00 Maintain
15/11/2017 Broker: Whitman Howard Rating: Buy New Target: GBX 680.00 Target Up
09/11/2017 Broker: Kepler Cheuvreux Rating: Reduce Old Target: GBX 560.00 New Target: GBX 560.00 Maintain
09/11/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 680.00 New Target: GBX 680.00 Maintain
06/11/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 680.00 New Target: GBX 680.00 Maintain
02/11/2017 Broker: Kepler Cheuvreux Rating: Reduce Old Target: GBX 560.00 New Target: GBX 560.00 Maintain

Among 19 analysts covering MetLife (NYSE:MET), 10 have Buy rating, 1 Sell and 8 Hold. Therefore 53% are positive. MetLife had 56 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, December 21 by Keefe Bruyette & Woods. Keefe Bruyette & Woods maintained it with “Buy” rating and $5500 target in Wednesday, April 11 report. The firm earned “Buy” rating on Monday, November 6 by Argus Research. J.P. Morgan initiated MetLife, Inc. (NYSE:MET) on Monday, July 24 with “Hold” rating. UBS maintained MetLife, Inc. (NYSE:MET) on Friday, March 2 with “Neutral” rating. The stock has “Neutral” rating by Credit Suisse on Friday, October 7. As per Wednesday, February 14, the company rating was maintained by Morgan Stanley. On Monday, August 29 the stock rating was maintained by FBR Capital with “Outperform”. RBC Capital Markets maintained MetLife, Inc. (NYSE:MET) rating on Monday, June 5. RBC Capital Markets has “Buy” rating and $6200 target. Wells Fargo maintained the shares of MET in report on Monday, July 10 with “Buy” rating.

Analysts await MetLife, Inc. (NYSE:MET) to report earnings on May, 2 after the close. They expect $1.17 EPS, down 19.86% or $0.29 from last year’s $1.46 per share. MET’s profit will be $1.21B for 10.26 P/E if the $1.17 EPS becomes a reality. After $1.11 actual EPS reported by MetLife, Inc. for the previous quarter, Wall Street now forecasts 5.41% EPS growth.

Investors sentiment increased to 1.02 in 2017 Q4. Its up 0.13, from 0.89 in 2017Q3. It increased, as 45 investors sold MET shares while 330 reduced holdings. 93 funds opened positions while 290 raised stakes. 782.94 million shares or 0.24% less from 784.85 million shares in 2017Q3 were reported. Moreover, Rampart Inv Mngmt Limited has 0.28% invested in MetLife, Inc. (NYSE:MET) for 14,430 shares. Axa has 0.03% invested in MetLife, Inc. (NYSE:MET) for 139,731 shares. Focused Wealth Mgmt reported 195 shares stake. Jennison Limited Liability stated it has 0.22% of its portfolio in MetLife, Inc. (NYSE:MET). Philadelphia Tru Com accumulated 34,455 shares or 0.14% of the stock. Stephens Ar invested 0.26% of its portfolio in MetLife, Inc. (NYSE:MET). Bnp Paribas Arbitrage holds 0.05% of its portfolio in MetLife, Inc. (NYSE:MET) for 544,585 shares. Utah Retirement Systems stated it has 168,327 shares. Ibm Retirement Fund reported 22,591 shares. Fulton Fincl Bank Na invested in 5,823 shares or 0.02% of the stock. Wedge Capital Management L Limited Partnership Nc, North Carolina-based fund reported 630,959 shares. Wunderlich Capital Managemnt has invested 0.86% of its portfolio in MetLife, Inc. (NYSE:MET). Mason Street Llc has 146,576 shares. Fifth Third National Bank & Trust accumulated 0.01% or 19,681 shares. Cleararc Cap invested in 0.18% or 26,798 shares.

The stock decreased 0.09% or GBX 0.5 during the last trading session, reaching GBX 540. About 146,426 shares traded. Dairy Crest Group plc (LON:DCG) has 0.00% since April 24, 2017 and is . It has underperformed by 11.55% the S&P500.

MetLife, Inc. (NYSE:MET) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>